Atea Pharmaceuticals, Inc. Common Stock

AVIRNASDAQUSD
4.99 USD
0.24 (5.05%)AT CLOSE (11:59 AM EDT)
4.88
0.12 (2.30%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
4.88
0.12 (2.30%)
🔴Market: CLOSED

Atea Pharmaceuticals, Inc. Common Stock (AVIR) trades at $5.01 per share. AVIR shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, AVIR appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Aug 6, 2026.

Open?$4.77
High?$5.02
Low?$4.76
Prev. Close?$4.75
Volume?245.3K
Avg. Volume?403.5K
VWAP?$4.90
Rel. Volume?0.61x
Bid / Ask
Bid?$4.80 × 5.0K
Ask?$5.50 × 200
Spread?$0.70
Midpoint?$5.15
Valuation & Ratios
Market Cap?380.1M
Shares Out?80.0M
Float?60.5M
Float %?75.5%
P/E Ratio?N/A
P/B Ratio?1.63
EPS?-$2.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Employees
55
Market Cap
380.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-10-30
Address
225 FRANKLIN STREET
BOSTON, MA 02110
Phone: (857) 284-8891
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+3/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
55
Momentum?
23
Short Sent.?
43
Piotroski F-Score?0/9Weak
Altman Z-Score?2.54Grey
Confidence?55%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?12.83%High
Short Interest?7.8M
Days to Cover?22.8
Free Float60.5M
Avg Daily Volume340.9K
Settlement Date2026-07-15
Financial Health
Current Ratio?7.89Strong
Quick Ratio?7.89Strong
Cash Ratio?2.38Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
84
1.63CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.6CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-72.5%WEAK
ROA?
S&P
3
-63.5%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$300.8M
Fundamentals ratios updated end of day